Changing Paradigms in Glaucoma Care By Steven D. Vold, MD
The Role of 24-Hour IOP Monitoring in Glaucoma
Continuous monitoring would allow clinicians to develop a more complete IOP profile on which to base long-term treatment goals for patients.
By Leonard K. Seibold, MD; Kaweh Mansouri, MD, MPH; Jeffrey R. SooHoo, MD; and Malik Y. Kahook, MD
The Future of Noninvasive Surgeries to Enhance Aqueous Outflow
Sonic energy and the modified delivery of laser energy appear to be the next wave.
By Jeffrey A. Kammer, MD
Sidebar: Micropulse Laser Trabeculoplasty By Iqbal Ike K. Ahmed, MD, FRCSC
Sidebar: Pattern Scanning Laser Trabeculoplasty By Miho Nozaki, MD, PhD
The Jigsaw Effect
Refined perimetric analysis confirms that the brain coordinates bilateral glaucomatous neurodegeneration to optimize the surviving binocular visual field.
By William Eric Sponsel, MD
The Effects of Changing Demographics on Ophthalmology
An increase in life expectancy means more need for eye care as the population ages.
By Norbert Pfeiffer, MD, PhD
Does Blood Flow Measurement Have a Role in Glaucoma Care?
Advanced imaging technologies and therapeutic options make blood flow measurement a prime consideration in glaucoma monitoring.
By Ahmad A. Aref, MD; Yali Jia, PhD; and David Huang, MD, PhD
Implanting a Valved Tube Shunt By Soosan Jacob, MS, FRCS, DNB
Ruminations for the Voting Booth
Ophthalmologists need to research candidates running for office before voting in the 2014 midterm elections.
By Jeffrey J. Kimbell and Kenneth L. Hodge
The Literature By Sunju Park, MD, and Assumpta Madu, MD, PharmD, MBA
Arthur J. Sit, SM, MD By Arthur J. Sit, SM, MD
Could Glaucoma Be a Two-Pressure Disease?
Research on the effects of space flight on the ocular system may help reveal if cerebrospinal fluid pressure plays a role in the development of glaucoma and idiopathic intracranial hypertension.
By John P. Berdahl, MD
The Societal Costs of Blindness From Uncontrolled Glaucoma By Yvonne N. Covin, MD; Daniel Laroche, MD; and Mildred M. G. Olivier, MD
Advances in 24-Hour IOP Monitoring
This technology will lead to more personalized care for patients.
By Robert Chang, MD
Diurnal IOP Control: How Important Is It?
Many glaucoma experts agree that IOP variation is important to evaluating and managing patients with glaucoma.
By Sanjay Asrani, MD
Enhancing Glaucoma Patients’ Adherence to Prescribed Medical Therapy
Tools to meet the challenge.
By Gail F. Schwartz, MD
New Horizons in Glaucoma Drug Delivery
Many products are in research and development, but there are numerous challenges.
By Gary D. Novack, PhD
Current Concepts in Laser Trabeculoplasty
Advances in technology make this option an attractive alternative or adjunct to medical therapy.
By Jason Bacharach, MD
Filtration Surgery: Indications and Improvements
The future of this intervention likely depends on the development of devices that communicate between the anterior chamber and the episcleral space.
By Michael Stiles, MD
The Evolving Indications for Microinvasive Glaucoma Surgery
Less surgery may be more.
By Robert Marquis, MD, PhD
Novel Risk Factors for Glaucoma
Research suggests that many issues other than IOP may play a role in the pathophysiology of glaucoma.
By Shan Lin, MD
The Literature By Joseph Panarelli, MD, and Lauren Blieden, MD
The Optometrist’s Role in Glaucoma Care
Involvement varies among providers for several reasons.
By Murray Fingeret, OD
Does the Integrated MD-OD Model Represent the Future?
Greater collaboration between these eye care specialists will have a growing role in the management of glaucoma patients.
By Anup K. Khatana, MD
The Evolving Role of Lens Extraction in Glaucoma Care
Cataract surgery lowers the IOP in eyes with many types of glaucoma.
By Marcos Reyes, MD
Laser Cataract Surgery in the Glaucoma Population
These patients present unique considerations and challenges, but many of them can benefit from the use of a femtosecond laser.
By Robert J. Noecker, MD, MBA
IOL Selection Considerations in Glaucoma Patients
Options vary with the severity of the disease.
By Norm Zabriskie, MD
Keratorefractive Surgery in Glaucoma Patients
Considerations for refractive and glaucoma surgeons.
By John P. Berdahl, MD
Medical Marijuana for Glaucoma Therapy
Despite the drug’s potential IOP-lowering capabilities, toxicity to the ocular surface is a major concern.
By Katherine Shen, OD
Strategies for building relationships with newly diagnosed patients and those with progressing glaucoma.
By Henry D. Jampel, MD, MHS; Richard J. Madonna, OD; Steven L. Mansberger, MD, MPH; Igor Estrovich, MD; Leo Semes, OD; Julia Song, MD; and Joseph Sowka, OD
Sidebar: Discussing Medical Marijuana with Glaucoma Patients By David Diaz, MD
Measuring the Impact of Glaucoma and the Value of Treatment
A primer on value-based medicine.
By Gary C. Brown, MD, MBA; Melissa M. Brown, MD, MN, MBA; Joshua D. Stein, MD, MSc, MS; Richard P. Wilson, MD; and George L. Spaeth, MD
Overview on Microinvasive Glaucoma Surgery
Where are we now?
By Reay H. Brown, MD
Surgical Pearls and Pitfalls With a Trabecular Microbypass Stent
The challenges and my approach for success.
By Constance O. Okeke, MD, MSCE
The Role of Suprachoroidal Stents
Where will they fit in the glaucoma treatment paradigm?
By Brian Flowers, MD